ClinicalTrials.gg
RecruitingNCT06971796EURO-STIMUpdated Sep 8, 2025

EURO-STIM Registry

An observational study in Obstructive Sleep Apnea and Obstructive Sleep Apnea (OSA), sponsored by Inspire Medical Systems, Inc.. Recruiting at 21 sites in 7 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-08.

Sponsored by Inspire Medical Systems, Inc. · Observational

How we know

From the registry’s dates

  • Started May 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Sleep Apnea, Obstructive by Inspire Medical Systems, Inc. — 5 open to participants now, 8 under way, none of them phase 3. Sleep Apnea, Obstructive · Inspire Medical Systems, Inc..

Started
2025
with 2 others
Observational
4 of 13
3 open now
Registered
12th of 13
by date

Among the 13 studies in Sleep Apnea, Obstructive by Inspire Medical Systems, Inc., this one is one of 3 that started in 2025, is one of 4 observational ones, and was the 12th registered.

Sleep Apnea, Obstructive

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

5 of the 13 studies in Sleep Apnea, Obstructive by Inspire Medical Systems, Inc. are open now, in 8 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Who these studies take

Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Sleep Apnea, Obstructive by Inspire Medical Systems, Inc., or all of them as a file.
02

Study summary

The registry is to measure longitudinal outcomes and adherence of the Inspire System. The goal of the registry is to capture the life cycle of the patient's use of the Inspire System through routine clinical care visits. There are no required interventions or testing.

03

Conditions studied

  • Obstructive Sleep Apnea
  • Obstructive Sleep Apnea (OSA)

Keywords

  • Sleep Apnea
  • OSA
  • Inspire
  • Obstructive Sleep Apnea
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients previously implanted or scheduled to be implanted with an Inspire System will be informed of the registry and given the option to participate by qualified Euro-Stim Registry staff. Up to 1,000 patients at up to 55 centers in multiple countries in the European Union and the United Kingdom will be included in the registry.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Any patient implanted with or receiving an Inspire implant, who meets the following criteria, is eligible to participate in the registry:

  1. Capable of giving , as required per institution
  2. Willing to return for routine clinic visits as required for Inspire therapy management

Exclusion criteria

Exclusion Criteria:

Any patient who meets any of the following criteria will not be eligible to participate in the registry:

  1. Has a of less than one year
  2. Any reason the clinician deems patient is unfit for participation in the study
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Target follow-up
10 Years
Patient registry
Yes

Interventions

  • DeviceInspire UAS System

    Participants will be implanted with the Inspire UAS System, which is a permanent, implantable therapy that consists of three implantable components: an IPG, a stimulation lead, and a sensing lead. In addition, the study subject receives a remote control to activate the therapy.

06

What researchers measure

Primary outcomes

  1. Apnea Hypopnea Index (AHI)

    The AHI, or number of apnea and hypopnea events per hour, is a measure of OSA severity.

    Time frame: Total AHI, supine and non-supine AHI, documented as events/hour of sleep will be collected at baseline, prior to implant, and at follow-up visits, if available, as determined by clinical standard of care.

  2. Epworth Sleepiness Scale (ESS)

    The ESS is a validated, self-report instrument that rates a subject's tendency to fall asleep in eight common daily situations13. The ESS has been validated primarily in OSA.

    Time frame: ESS will be collected at baseline and follow-up visits, if available, as determined by clinical standard of care.

Secondary outcomes

  1. DISE VOTE Classification

    A Drug-Induced Sleep Endoscopy (DISE) is a diagnostic, standard of care procedure performed as part of the evaluation for airway surgeries (including implant of the Inspire System). The DISE is utilized to visualize the patient's airway obstruction.

    Time frame: DISE VOTE Score will be collected, if available, at baseline.

  2. Functional Outcomes of Sleep Questionnaire (FOSQ-30)

    The FOSQ-30 is a validated, quality of life measurement that assesses the effect of a subject's daytime sleepiness on activities of ordinary living. It is commonly used in the clinical evaluation and management of OSA.

    Time frame: FOSQ-30 will be collected at baseline and follow-up visits, if available and only if already collected as part of routine clinical care.

  3. Patient Experience with Therapy (PET)

    The PET is a survey designed to collect information about patient's experience with the Inspire therapy.

    Time frame: PET will be collected at follow-up visits after device activation, if available.

  4. Maintenance of Wakefulness Test (MWT)

    The maintenance of wakefulness test is used to measure a person's ability to stay awake during a defined period of time.

    Time frame: Sleep latency is recorded in minutes and may be collected from a maintenance of wakefulness test performed at baseline and follow-up visits after device activation, if available.

  5. Therapy Use

    Therapy use, reported as hours of use per week, is recorded during follow-up visits and will be collected from the Inspire physician programmer.

    Time frame: Therapy use will be collected at follow-up visits after device activation, if available.

  6. Adverse Events

    Both serious and non-serious procedure-related and device/therapy related adverse events will be collected and reported.

    Time frame: The number of events (as well as the % of subjects in which the event occurred) will be reported at implant and at follow-up timepoints.

07

Study locations

3 of 21 sites recruiting
  • Klinikum Klagenfurt, KABEG
    Klagenfurt, Austria
    Not yet recruiting
    • Dr. Andreas Bischof · Contactandreas.bischof@kabeg.at
    • Dr. Andreas Bischof · Principal investigator
    • Dr. Hanna Obermeier · Principal investigator
  • Ordensklinikum Linz
    Linz, Austria
    Not yet recruiting
  • Universitair Ziekenhuis Antwerpen
    Edegem, Belgium
    Not yet recruiting
    • Dorine Van Loo, PhD. · Contactdorine.vanloo@uza.be
    • Prof. Dr. Olivier Vanderveken · Principal investigator
  • Angers University Hospital Center
    Angers, France
    Not yet recruiting
  • CHU Grenoble Alpes
    La Tronche, France
    Not yet recruiting
  • Clinique de la Louviere
    Lille, France
    Not yet recruiting
    • Dr. Sarah Boulanger · Contactsarahboulanger.pneumo@gmail.com
    • Dr. Sarah Boulanger · Principal investigator
    • Dr. Thibaut Gentina · Principal investigator
  • Hôpital d'Instruction des Armées Laveran
    Marseille, France
    Not yet recruiting
    • Dr. Stanislas Ballivet de Regloix · Contact
    • Dr. Allali Laure · Principal investigator
  • Clinique Beausoleil
    Montpellier, France
    Not yet recruiting
  • CHU Saint Etienne
    Saint-Priest-en-Jarez, France
    Not yet recruiting
  • Asklepios Klinik Hamburg
    Hamburg, Germany
    Recruiting
  • Universitatsklinikum Hamburg Eppendorf
    Hamburg, Germany
    Recruiting
    • Prof. Dr. med Arne Boettcher · Contactar.boettcher@uke.de
    • Prof. Dr. med Arne Boettcher · Principal investigator
  • Klinik für HNO-Heilkunde/HNO-Schlaflabor
    Lübeck, Germany
    Not yet recruiting
    • Dr. med. Armin Steffen · ContactArmin.Steffen@uksh.de
    • Dr. med. Armin Steffen · Principal investigator
  • Otto-von-Guericke-Universität Magdeburg
    Magdeburg, Germany
    Not yet recruiting
    • Dr.Stephanie Kühne · Contactstephanie.kuehne@med.ovgu.de
    • Dr.Stephanie Kühne · Principal investigator
    • Dr.Anja Giers · Principal investigator
  • Universitäts-HNO-Klinik Mannheim
    Mannheim, Germany
    Not yet recruiting
  • Klinikum Rechts der Isar Technische Universität München
    Munich, Germany
    Recruiting
  • Sint Lucas Andreas Ziekenhus (OLVG)
    Amsterdam, Netherlands
    Not yet recruiting
  • St. Antonius Ziekenhuis Nieuwegein
    Nieuwegein, Netherlands
    Not yet recruiting
  • Kantonnspital Baselland-Liestal
    Liestal, Switzerland
    Not yet recruiting
    • Prof. Dr. Kurt Tschopp · Contactkurt.tschopp@ksbl.ch
    • Prof. Dr. Kurt Tschopp · Principal investigator
  • Guy's & St Thomas' NHS Foundation Trust
    London, United Kingdom
    Not yet recruiting
    • Krizzia Lammas · Contactkrizzia.lammas@gstt.nhs.uk
    • Prof. Joerg Steier · Principal investigator
    • Yakubu Karagama · Principal investigator
  • University College London Hospitals NHS Foundation Trust
    London, United Kingdom
    Not yet recruiting
    • Omursen Yildirim · Contactomursen.yildirim@nhs.net
    • Ryan Chin Taw Cheong · Principal investigator
    • Sara McNeillis · Principal investigator
  • Manchester University NHS Trust
    Manchester, United Kingdom
    Not yet recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Apr 2035, 119 months after the start.

Of 36 industry-sponsored observational studies under Sleep Apnea, Obstructive, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 93. This study's planned 119 months is above that.

Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 14 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 7, 2025
First posted
May 14, 2025
StartActual
May 26, 2025
Primary completionEst.
Apr 2035
CompletionEst.
Apr 2035
Last update
Sep 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06971796
Lead sponsor
Inspire Medical Systems, Inc.
Responsible party
Sponsor
First posted
May 14, 2025
Start date
May 26, 2025
Primary completion
Apr 2035 (estimated)
Completion
Apr 2035 (estimated)
Last update
Sep 8, 2025

Study contacts

Elyse Ebeling
Contact
elyseebeling@inspiresleep.com
(763) 250-9432

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion